Navigation Links
Worldwide War Deaths Underestimated
Date:6/19/2008

stimates of 58,000, the report shows. In Zimbabwe, the researchers estimate that 130,000 people have died in times of conflict, compared with earlier estimates of 28,000.

The findings are published in the June 20 online edition of the British Medical Journal.

According to the authors, current methods of collecting data on those killed during war are plagued by biases that produce inaccuracies and underestimate the number of people actually killed. This can lead to widely varying casualty estimates. For example, in Iraq, a report published in the medical journal The Lancet in 2006 estimated that 650,000 Iraqi civilians had been killed by that time since the start of the war -- a claim disputed by the White House, whose own estimates put the death toll at 30,000.

In their study, Obermeyer's team drew on several sources to try to more accurately estimate the number of military and civilian deaths from recent wars. Their estimates do not include people who died during the war from starvation, sickness or other conditions indirectly caused by war.

"There is a notion in political thought that the number of deaths due to war has been declining in recent years," Obermeyer noted. "That is attributed to a lot of different things, but among them technological innovations like 'smart' bombs and different strategic priorities. This idea appears to be supported by media reports. But what we are finding is these reports are not a reflection of reality."

Contemporary media reports of deaths are not to be fully trusted, Obermeyer addeds. "The reason we should be skeptical of media reports is that they are subject to political pressures and cannot always be verified," he said. "These numbers can be pushed up or down, depending upon what kind of political pressure is being exerted."

Richard Garfield, a professor of clinical international nursing at Columbia University in New York City and the author of
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Agendia Expands Laboratory Capacity at New Amsterdam Headquarters to Meet Increasing Demand for Services Worldwide
2. Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
3. Worldwide Pharmaceutical Industry, Aid Organizations Warn of Second Disaster in Myanmar
4. Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
5. AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide
6. Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide
7. Self Regional Healthcare One of 20 Organizations Worldwide to Bring Home Workplace Award from Gallup
8. Centers for Medicare & Medicaid Services Awards Ogilvy Public Relations Worldwide $1.4 Million Dollar Contract
9. Michel Nakache Returns to Euro RSCG Life as Worldwide Managing Partner
10. Historic Fundraising Initiative to Empower Women & Girls Worldwide Reaches $100 Million Quickly Even as U.S. Economy Slows
11. AUDIO from Medialink and Safe Kids Worldwide: Accidental Childhood Injury Death Rate Down 45%
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Worldwide War Deaths Underestimated
Worldwide War Deaths Underestimated
Breaking Medicine Technology:OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 1NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 2NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 3Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia 6211 1Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia 6211 2Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia 6211 3Gene Therapy Brings New Muscle to Monkeys 61251 1
Other Medicine Technology:Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 2Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 3Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 4Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 5Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 6